Nixon DF - Search Results

1

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, McGee P, Zamb T, Koff W, Wang CY, O'Hagan D. Nixon DF, et al. Vaccine. 1996 Nov;14(16):1523-30. doi: 10.1016/s0264-410x(96)00099-0. Vaccine. 1996. PMID: 9014294 Free article.

2

Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.

Hioe CE, Qiu H, Chend PD, Bian Z, Li ML, Li J, Singh M, Kuebler P, McGee P, O'Hagan D, Zamb T, Koff W, Allsopp C, Wang CY, Nixon DF. Hioe CE, et al. Among authors: nixon df. Vaccine. 1996 Apr;14(5):412-8. doi: 10.1016/0264-410x(95)00191-3. Vaccine. 1996. PMID: 8735553 Free article.

3

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization.

Allsopp CE, Plebanski M, Gilbert S, Sinden RE, Harris S, Frankel G, Dougan G, Hioe C, Nixon D, Paoletti E, Layton G, Hill AV. Allsopp CE, et al. Eur J Immunol. 1996 Aug;26(8):1951-9. doi: 10.1002/eji.1830260841. Eur J Immunol. 1996. PMID: 8765044

4

Cytotoxic T cell induction with ratchet peptide libraries.

Kuebler PJ, Nixon DF. Kuebler PJ, et al. Among authors: nixon df. Vaccine. 1996 Dec;14(17-18):1664-70. doi: 10.1016/s0264-410x(96)00125-9. Vaccine. 1996. PMID: 9032897

5

CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.

Singh M, Hioe C, Qiu H, Li XM, Wang CY, Koff W, Zamb T, Nixon DF. Singh M, et al. Among authors: nixon df. Vaccine. 1997 Nov;15(16):1773-8. doi: 10.1016/s0264-410x(97)00109-6. Vaccine. 1997. PMID: 9364682 Free article.

6

Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.

Nixon DF, Douek D, Kuebler PJ, Jin X, Vesanen M, Bonhoeffer S, Cao Y, Koup RA, Ho DD, Markowitz M. Nixon DF, et al. Immunol Lett. 1999 Mar;66(1-3):219-28. doi: 10.1016/s0165-2478(98)00162-x. Immunol Lett. 1999. PMID: 10203058

7

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals.

Seth A, Yasutomi Y, Jacoby H, Callery JC, Kaminsky SM, Koff WC, Nixon DF, Letvin NL. Seth A, et al. Among authors: nixon df. AIDS Res Hum Retroviruses. 2000 Mar 1;16(4):337-43. doi: 10.1089/088922200309214. AIDS Res Hum Retroviruses. 2000. PMID: 10716371 Clinical Trial.

8

Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF. Sharp ER, et al. Among authors: nixon df. PLoS One. 2011;6(7):e21135. doi: 10.1371/journal.pone.0021135. Epub 2011 Jul 19. PLoS One. 2011. PMID: 21818255 Free PMC article.

9

Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.

Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, E Sheehy M, Ortiz GM, S Ogg G, Barbour JD, Lenz J, Steinfeld AD, Nixon DF. Rakoff-Nahoum S, et al. Among authors: nixon df. AIDS Res Hum Retroviruses. 2006 Jan;22(1):52-6. doi: 10.1089/aid.2006.22.52. AIDS Res Hum Retroviruses. 2006. PMID: 16438646

10

Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children.

Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, Nixon DF. Sharp ER, et al. Among authors: nixon df. PLoS One. 2012;7(1):e29154. doi: 10.1371/journal.pone.0029154. Epub 2012 Jan 11. PLoS One. 2012. PMID: 22247768 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters